Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis JU Scher, A Sczesnak, RS Longman, N Segata, C Ubeda, C Bielski, ... elife 2, e01202, 2013 | 1981 | 2013 |
Bile acid metabolites control TH17 and Treg cell differentiation S Hang, D Paik, L Yao, E Kim, J Trinath, J Lu, S Ha, BN Nelson, SP Kelly, ... Nature 576 (7785), 143-148, 2019 | 897 | 2019 |
Maternal gut bacteria promote neurodevelopmental abnormalities in mouse offspring S Kim, H Kim, YS Yim, S Ha, K Atarashi, TG Tan, RS Longman, K Honda, ... Nature 549 (7673), 528-532, 2017 | 637 | 2017 |
Regulation of inflammation by microbiota interactions with the host JM Blander, RS Longman, ID Iliev, GF Sonnenberg, D Artis Nature immunology 18 (8), 851-860, 2017 | 607 | 2017 |
Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX3CR1hi cells GE Diehl, RS Longman, JX Zhang, B Breart, C Galan, A Cuesta, ... Nature 494 (7435), 116-120, 2013 | 513 | 2013 |
A two-step induction of indoleamine 2, 3 dioxygenase (IDO) activity during dendritic-cell maturation D Braun, RS Longman, ML Albert Blood 106 (7), 2375-2381, 2005 | 501 | 2005 |
Expansion of bacteriophages is linked to aggravated intestinal inflammation and colitis L Gogokhia, K Buhrke, R Bell, B Hoffman, DG Brown, C Hanke-Gogokhia, ... Cell host & microbe 25 (2), 285-299. e8, 2019 | 439 | 2019 |
CX3CR1+ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22 RS Longman, GE Diehl, DA Victorio, JR Huh, C Galan, ER Miraldi, ... Journal of Experimental Medicine 211 (8), 1571-1583, 2014 | 391 | 2014 |
Human gut bacteria produce ΤΗ17-modulating bile acid metabolites D Paik, L Yao, Y Zhang, S Bae, GD D’Agostino, M Zhang, E Kim, ... Nature 603 (7903), 907-912, 2022 | 313 | 2022 |
IgA-coated E. coli enriched in Crohn’s disease spondyloarthritis promote TH17-dependent inflammation M Viladomiu, C Kivolowitz, A Abdulhamid, B Dogan, D Victorio, ... Science translational medicine 9 (376), eaaf9655, 2017 | 281 | 2017 |
Presence of functional dendritic cells in patients chronically infected with hepatitis C virus RS Longman, AH Talal, IM Jacobson, ML Albert, CM Rice Blood 103 (3), 1026-1029, 2004 | 195 | 2004 |
Critical role for the microbiota in CX3CR1+ intestinal mononuclear phagocyte regulation of intestinal T cell responses M Kim, C Galan, AA Hill, WJ Wu, H Fehlner-Peach, HW Song, D Schady, ... Immunity 49 (1), 151-163. e5, 2018 | 188 | 2018 |
Thymic development of gut-microbiota-specific T cells DF Zegarra-Ruiz, DV Kim, K Norwood, M Kim, WJH Wu, ... Nature 594 (7863), 413-417, 2021 | 157 | 2021 |
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes G Barba-Spaeth, RS Longman, ML Albert, CM Rice The Journal of experimental medicine 202 (9), 1179-1184, 2005 | 156 | 2005 |
Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C RS Longman, AH Talal, IM Jacobson, CM Rice, ML Albert The Journal of infectious diseases 192 (3), 497-503, 2005 | 155 | 2005 |
Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients J Decalf, S Fernandes, R Longman, M Ahloulay, F Audat, F Lefrerre, ... The Journal of experimental medicine 204 (10), 2423-2437, 2007 | 154 | 2007 |
Microbiota-induced TNF-like ligand 1A drives group 3 innate lymphoid cell-mediated barrier protection and intestinal T cell activation during colitis JG Castellanos, V Woo, M Viladomiu, G Putzel, S Lima, GE Diehl, ... Immunity 49 (6), 1077-1089. e5, 2018 | 129 | 2018 |
Single delivery of high-diversity fecal microbiota preparation by colonoscopy is safe and effective in increasing microbial diversity in active ulcerative colitis V Jacob, C Crawford, S Cohen-Mekelburg, M Viladomiu, GG Putzel, ... Inflammatory bowel diseases 23 (6), 903-911, 2017 | 118 | 2017 |
Dual biologic or small molecule therapy for treatment of inflammatory bowel disease: a systematic review and meta-analysis W Ahmed, J Galati, A Kumar, PJ Christos, R Longman, DJ Lukin, E Scherl, ... Clinical Gastroenterology and Hepatology 20 (3), e361-e379, 2022 | 114 | 2022 |
Baseline disease activity and steroid therapy stratify risk of COVID-19 in patients with inflammatory bowel disease DJ Lukin, A Kumar, K Hajifathalian, RZ Sharaiha, EJ Scherl, RS Longman, ... Gastroenterology 159 (4), 1541-1544. e2, 2020 | 112 | 2020 |